Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5445 Journals
4171 Congresses
9600+ Unique Records

Therapeutic Advances in Drug Safety


Title Abbreviation
Ther Adv Drug Saf
ISSN
2042-0986
Electronic ISSN
2042-0994
Readership
Clinical Pharmacologists, Clinicians, Geriatricians, Internists, Pharmacists, Pharmaco-Epidemiologists, Researchers
Scope
Therapeutic Advances in Drug Safety delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area. Aims and Scope Therapeutic Advances in Drug Safety delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area. Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract. The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
SAGE Publications - UK
To see more details about Therapeutic Advances in Drug Safety, Subscribe Now!
Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library